Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 October 2023 | Story Reuben Maeko | Photo SUPPLIED
Dr Tabane
Dr Lizzy Tabane, Head of Paediatrics and Child Health in the Faculty of Health Sciences at the University of the Free State, gives a message of support at the 2023 SAPA Conference.

The Department of Paediatrics and Child Health at the University of the Free State (UFS) recently hosted the 2023 South African Paediatric Association conference (SAPA) in Sandton, Johannesburg, with more than 200 doctors, specialists and registrars in attendance. 

The conference aimed to provide high-quality, evidence-based updates on children’s health issues and research in health care. The three-day conference focused on presentations from various paediatricians in South Africa’s health sectors.

Conference presentations 

The conference explored new ways of treating different types of childhood diseases, and covered a range of topics such as learning disabilities and inclusive education, sports for children with asthma, septic shock, dyslipidaemia in children, congenital heart disease among others.

Collaborations with healthcare professionals

Head of Paediatrics and Child Health at the UFS, Dr Lizzy Tabane and her colleagues, Dr Mampoi Jonas and Prof Ute Hallbauer, were pleased with the success and outcome of the conference. 

According to Dr Tabane, the professionals gather once a year to learn, exchange ideas and work together to ensure the best possible care for children in hospitals. 

“The SAPA conference presents health professionals across South Africa with the latest information on paediatric health. It also ensures that children in our country continue to receive quality care through an integrated approach by allowing health professionals to connect, network, and share their knowledge and expertise,” said Dr Jonas.

“The country and the community at large are in good hands,” said Dr Tabane. “Let us not fall behind but catch up with the latest innovations, for instance, Artificial Intelligence and Machine Learning in Medicine. Our partnership with all paediatrics and other health professionals will bring unity and good child health care in our country."

“What is important is the tremendous support from all the specialists, doctors and practice nurses from different health-care departments who have consistently turned out in large numbers. The success of the conference extends beyond GPs, such as drawing in specialists, clinicians, nurses, and professionals dedicated to children’s well-being within hospitals and the community,” emphasised Dr Tabane.

Significance of the conference

Prof Hallbauer emphasised the significance of fostering collaboration to enhance integrated care, spanning both the hospital system and primary care. “This annual conference confirms our commitment to working together as doctors for the well-being of our patients. The motto we have chosen is Carpe Diem ‘Seize the Day’. For the conference this means taking hold of the programme and making the most of each conference day. 

“When you meet your colleagues, build and strengthen the collegial networks, so that we can realise Letshwele le beta phoho – a SeSotho idiom meaning ‘The crowd beats the bull’,” added Prof Hallbauer. 

This conference “will strengthen our relationship” with other doctors and make the health system a better place, concluded Prof Hallbauer. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept